Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Creatine kinase–mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved
Ashish Gupta, … , Gary Gerstenblith, Robert G. Weiss
Ashish Gupta, … , Gary Gerstenblith, Robert G. Weiss
Published December 27, 2011
Citation Information: J Clin Invest. 2012;122(1):291-302. https://doi.org/10.1172/JCI57426.
View: Text | PDF
Research Article Cardiology

Creatine kinase–mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved

  • Text
  • PDF
Abstract

ATP is required for normal cardiac contractile function, and it has long been hypothesized that reduced energy delivery contributes to the contractile dysfunction of heart failure (HF). Despite experimental and clinical HF data showing reduced metabolism through cardiac creatine kinase (CK), the major myocardial energy reserve and temporal ATP buffer, a causal relationship between reduced ATP-CK metabolism and contractile dysfunction in HF has never been demonstrated. Here, we generated mice conditionally overexpressing the myofibrillar isoform of CK (CK-M) to test the hypothesis that augmenting impaired CK-related energy metabolism improves contractile function in HF. CK-M overexpression significantly increased ATP flux through CK ex vivo and in vivo but did not alter contractile function in normal mice. It also led to significantly increased contractile function at baseline and during adrenergic stimulation and increased survival after thoracic aortic constriction (TAC) surgery–induced HF. Withdrawal of CK-M overexpression after TAC resulted in a significant decline in contractile function as compared with animals in which CK-M overexpression was maintained. These observations provide direct evidence that the failing heart is “energy starved” as it relates to CK. In addition, these data identify CK as a promising therapeutic target for preventing and treating HF and possibly diseases involving energy-dependent dysfunction in other organs with temporally varying energy demands.

Authors

Ashish Gupta, Ashwin Akki, Yibin Wang, Michelle K. Leppo, V.P. Chacko, D. Brian Foster, Viviane Caceres, Sa Shi, Jonathan A. Kirk, Jason Su, Shenghan Lai, Nazareno Paolocci, Charles Steenbergen, Gary Gerstenblith, Robert G. Weiss

×

Figure 5

Functional and survival effects of CK-M overexpression in TAC hearts.

Options: View larger image (or click on image) Download as PowerPoint
Functional and survival effects of CK-M overexpression in TAC hearts.
(A...
(A) Time course of experimental protocol and (B) typical transverse in vivo 1H MR images of the mid-LV at end-systole and end-diastole after 8 weeks of sham or TAC surgery in control and CK-M mice. (C) Summary MRI findings (mean ± SD) at 4 and 8 weeks showing EF, SV, and CO in CK-M sham (open circles, n = 8) and control sham (X, n = 9) mice, as well as in CK-M TAC (filled circles, dashed lines, n = 8) and control TAC mice (filled diamonds, solid lines, n = 13). (D) In vivo cardiac PCr/ATP ratio in control sham (n = 9), control with TAC (n = 13 at 4 weeks, n = 9 at 8 weeks), CK-M overexpressor (Overexp) sham (n = 8), and CK-M with TAC (Overexp TAC; n = 8 at 4 weeks, n = 7 at 8 weeks) mouse hearts. (E) Kaplan-Meier survival curve showing improved survival following TAC in CK-M mice (dotted line n = 18) as compared with control mice (solid line, n = 17). *P < 0.05, **P < 0.001, ***P < 0.0001.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts